{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:52:09Z","timestamp":1790373129297,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Determinants of long-term disability in multiple sclerosis (MS) remain incompletely understood, with clinical course varying greatly among individuals. Recent integrative genetic models have identified genomic clusters associated with divergent disability trajectories. Here, we integrated clinical, genetic, and postmortem neuropathological data from 291 MS brain donors from the UK MS Society Tissue Bank to test whether genomic severity clusters converge on distinct tissue phenotypes. Consistent with prior stratification, donors in genomic cluster 2 had lower age-adjusted disease duration score (ADDS) than cluster 3 (\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u2009\u2212\u00a00.195,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.023) and a shorter interval from progression to death than cluster 1 (\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u2009\u2212\u00a00.225,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.049). However, this adverse clinical profile did not reflect greater active or chronic active lesion burden. Instead, chronic active broad-rim lesions were more frequent in cluster 1 than clusters 2 and 3 (37.3% vs 24.0% and 27.2%; both FDR\u2009=\u20090.043), whereas chronic inactive lesions were enriched in clusters 2 and 3 relative to cluster 1 (58.2% vs 70.0% and 73.8%; FDR\u2009=\u20090.154 and 0.030, respectively). This dissociation was strongly influenced by HLA genetic background: cluster 1 carried the highest HLA genetic burden, which was associated with greater non-lesional HLA-D immunoreactivity (rho\u2009=\u20090.48, FDR\u2009&lt;\u20090.001), higher HLA-DRB1 (rho\u2009=\u20090.514, FDR\u2009&lt;\u20090.001) and HLA-DRB5 (rho\u2009=\u20090.740, FDR\u2009&lt;\u20090.001) mRNA expression, more active lesions (rho\u2009=\u20090.21, FDR\u2009=\u20090.007) and chronic active broad-rim lesions (rho\u2009=\u20090.19, FDR\u2009=\u20090.017), and fewer chronic inactive lesions (rho\u2009=\u2009\u2212\u00a00.26, FDR\u2009&lt;\u20090.001), but not with clinical severity. Although chronic active lesion burden remained a strong tissue correlate of severity, adjustment for it strengthened the association between cluster 2 and worse outcome (ADDS: cluster 2 vs 1:\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u2009\u2212\u00a00.216, Holm-adjusted\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.038; cluster 2 vs 3:\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u2009\u2212\u00a00.246, Holm-adjusted\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.012; time from progression to death: cluster 2 vs 1:\n                    <jats:italic>\u03b2<\/jats:italic>\n                    \u2009=\u2009\u2212\u00a00.288, Holm-adjusted\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.049). Overall, these findings indicate that (i) HLA genetic background shapes the neuropathological representation of inflammatory lesions, and (ii) the adverse clinical profile of cluster 2 is not fully explained by HLA-D-defined chronic active lesion burden in the sampled postmortem tissue, suggesting that genomic severity clusters and chronic active lesion burden capture complementary aspects of MS progression.\n                  <\/jats:p>","DOI":"10.1007\/s00401-026-03062-x","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:02:51Z","timestamp":1787310171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic subtypes of multiple sclerosis severity are uncoupled from inflammatory lesion burden"],"prefix":"10.1007","volume":"152","author":[{"given":"Gianmarco","family":"Abbadessa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim L.","family":"Kreft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owain","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Victor Carlos","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Cooze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemis","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joic Majo","family":"Jacinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeung-Yeung","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bonavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma Clare","family":"Tallantyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie","family":"Rizig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Magliozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"2","key":"3062_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s100720170012","volume":"22","author":"IV Allen","year":"2001","unstructured":"Allen IV, McQuaid S, Mirakhur M, Nevin G (2001) Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci 22(2):141\u2013144. https:\/\/doi.org\/10.1007\/s100720170012","journal-title":"Neurol Sci"},{"issue":"1","key":"3062_CR2","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7(1):16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5","journal-title":"Sci Rep"},{"issue":"12","key":"3062_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cells13121020","volume":"13","author":"B Cooze","year":"2024","unstructured":"Cooze B, Neal J, Vineed A, Oliveira JC, Griffiths L, Allen KH et al (2024) Digital pathology identifies associations between tissue inflammatory biomarkers and multiple sclerosis outcomes. Cells 13(12):1020. https:\/\/doi.org\/10.3390\/cells13121020","journal-title":"Cells"},{"issue":"1","key":"3062_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nmeth.2307","volume":"10","author":"O Delaneau","year":"2013","unstructured":"Delaneau O, Zagury JF, Marchini J (2013) Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods 10(1):5\u20136. https:\/\/doi.org\/10.1038\/nmeth.2307","journal-title":"Nat Methods"},{"issue":"2","key":"3062_CR5","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000656","volume":"7","author":"LS Enz","year":"2019","unstructured":"Enz LS, Zeis T, Schmid D, Geier F, van der Meer F, Steiner G et al (2019) Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15. Neurol Neuroimmunol Neuroinflamm 7(2):e656. https:\/\/doi.org\/10.1212\/NXI.0000000000000656","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"3062_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ana.24497","volume":"78","author":"JM Frischer","year":"2015","unstructured":"Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I et al (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol 78(5):710\u2013721. https:\/\/doi.org\/10.1002\/ana.24497","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"3062_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/brain\/awv398","volume":"139","author":"L Haider","year":"2016","unstructured":"Haider L, Zrzavy T, Hametner S, H\u00f6ftberger R, Bagnato F, Grabner G et al (2016) The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 139(Pt 3):807\u2013815. https:\/\/doi.org\/10.1093\/brain\/awv398","journal-title":"Brain"},{"issue":"Pt 12","key":"3062_CR8","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1093\/brain\/awl290","volume":"129","author":"OW Howell","year":"2006","unstructured":"Howell OW, Palser A, Polito A, Melrose S, Zonta B, Scheiermann C et al (2006) Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain 129(Pt 12):3173\u20133185. https:\/\/doi.org\/10.1093\/brain\/awl290","journal-title":"Brain"},{"issue":"Pt 9","key":"3062_CR9","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM et al (2011) Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134(Pt 9):2755\u20132771. https:\/\/doi.org\/10.1093\/brain\/awr182","journal-title":"Brain"},{"key":"3062_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.2354","volume":"44","author":"B Howie","year":"2012","unstructured":"Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44:955\u2013959. https:\/\/doi.org\/10.1038\/ng.2354","journal-title":"Nat Genet"},{"issue":"6460","key":"3062_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav7188","volume":"365","author":"International Multiple Sclerosis Genetics Consortium","year":"2019","unstructured":"International Multiple Sclerosis Genetics Consortium (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365(6460):eaav7188. https:\/\/doi.org\/10.1126\/science.aav7188","journal-title":"Science"},{"issue":"7969","key":"3062_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","volume":"619","author":"International Multiple Sclerosis Genetics Consortium","year":"2023","unstructured":"International Multiple Sclerosis Genetics Consortium, MultipleMS Consortium (2023) Locus for severity implicates CNS resilience in progression of multiple sclerosis. Nature 619(7969):323\u2013331. https:\/\/doi.org\/10.1038\/s41586-023-06250-x","journal-title":"Nature"},{"issue":"6","key":"3062_CR13","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1093\/brain\/awac449","volume":"146","author":"VG Jokubaitis","year":"2023","unstructured":"Jokubaitis VG, Campagna MP, Ibrahim O, Stankovich J, Kleinova P, Matesanz F et al (2023) Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity. Brain 146(6):2316\u20132331. https:\/\/doi.org\/10.1093\/brain\/awac449","journal-title":"Brain"},{"issue":"6","key":"3062_CR14","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/s41591-025-03625-7","volume":"31","author":"L Klotz","year":"2025","unstructured":"Klotz L, Smolders J, Lehto J, Matilainen M, L\u00fctje L, Buchholz L et al (2025) Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis. Nat Med 31(6):2016\u20132026. https:\/\/doi.org\/10.1038\/s41591-025-03625-7","journal-title":"Nat Med"},{"issue":"5","key":"3062_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/jnnp-2025-337337","volume":"97","author":"KL Kreft","year":"2026","unstructured":"Kreft KL, Mekkes NJ, Uzochukwu E, Loveless S, Wynford-Thomas R, Harding KE et al (2026) Genetic subtypes associated with multiple sclerosis severity and response to treatment. J Neurol Neurosurg Psychiatry 97(5):413\u2013421. https:\/\/doi.org\/10.1136\/jnnp-2025-337337","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"3062_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.26831","volume":"95","author":"KL Kreft","year":"2024","unstructured":"Kreft KL, Uzochukwu E, Loveless S, Willis M, Wynford-Thomas R, Harding KE et al (2024) Relevance of multiple sclerosis severity genotype in predicting disease course: a real-world cohort. Ann Neurol 95(3):459\u2013470. https:\/\/doi.org\/10.1002\/ana.26831","journal-title":"Ann Neurol"},{"issue":"Pt 11","key":"3062_CR17","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C, Br\u00fcck W, Rauschka H, Bergmann M et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(Pt 11):2705\u20132712. https:\/\/doi.org\/10.1093\/brain\/awh641","journal-title":"Brain"},{"issue":"12","key":"3062_CR18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1001\/archneur.63.12.1686","volume":"63","author":"A Langer-Gould","year":"2006","unstructured":"Langer-Gould A, Popat RA, Huang SM, Cobb K, Fontoura P, Gould MK et al (2006) Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol 63(12):1686\u20131691. https:\/\/doi.org\/10.1001\/archneur.63.12.1686","journal-title":"Arch Neurol"},{"issue":"4","key":"3062_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","volume":"135","author":"S Luchetti","year":"2018","unstructured":"Luchetti S, Fransen NL, van Eden CG, Ramaglia V, Mason M, Huitinga I (2018) Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol 135(4):511\u2013528. https:\/\/doi.org\/10.1007\/s00401-018-1818-y","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3062_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuron.2024.11.016","volume":"113","author":"W Macnair","year":"2025","unstructured":"Macnair W, Calini D, Agirre E, Bryois J, J\u00e4kel S, Smith RS et al (2025) snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses. Neuron 113(3):396-410.e9. https:\/\/doi.org\/10.1016\/j.neuron.2024.11.016","journal-title":"Neuron"},{"issue":"Pt 4","key":"3062_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M et al (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130(Pt 4):1089\u20131104. https:\/\/doi.org\/10.1093\/brain\/awm038","journal-title":"Brain"},{"issue":"7","key":"3062_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159210","volume":"11","author":"JE Martin","year":"2016","unstructured":"Martin JE, Raffel J, Nicholas R (2016) Progressive dwindling in multiple sclerosis: an opportunity to improve care. PLoS ONE 11(7):e0159210. https:\/\/doi.org\/10.1371\/journal.pone.0159210","journal-title":"PLoS ONE"},{"issue":"4","key":"3062_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ana.26870","volume":"95","author":"R Nicholas","year":"2024","unstructured":"Nicholas R, Magliozzi R, Marastoni D, Howell O, Roncaroli F, Muraro P et al (2024) High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective postmortem cohort study. Ann Neurol 95(4):706\u2013719. https:\/\/doi.org\/10.1002\/ana.26870","journal-title":"Ann Neurol"},{"issue":"2","key":"3062_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378(2):169\u2013180. https:\/\/doi.org\/10.1056\/NEJMra1401483","journal-title":"N Engl J Med"},{"key":"3062_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.110266","volume":"265","author":"S Sartoris","year":"2024","unstructured":"Sartoris S, Del Pozzo G (2024) Exploring the HLA complex in autoimmunity: from the risk haplotypes to the modulation of expression. Clin Immunol 265:110266. https:\/\/doi.org\/10.1016\/j.clim.2024.110266","journal-title":"Clin Immunol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03062-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-026-03062-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03062-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:02:51Z","timestamp":1787310171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-026-03062-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3062"],"URL":"https:\/\/doi.org\/10.1007\/s00401-026-03062-x","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GA received speaker honoraria from Novartis. SB received speaker honoraria and\/or advisory board fee and\/or travel grant from Roche, Biogen, Merck-Serono, Juvise, Alexion, Novartis.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No identifiable individual-level data are reported.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24"}}